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eSUPPLEMENT 1
As an exploratory analysis, we assessed whether the relationship between recent peripheral glycemia and cerebral glucose levels is different between patients with well-controlled (lifetime hemoglobin A 1c [HbA 1c ] level Ͻ7%) and poorly controlled (Ն7%) type 1 diabetes mellitus (T1DM). If so, this would suggest that cerebral capability to maintain steady glucose levels can decline over a prolonged period with high blood glucose levels.
METHODS
Current HbA 1c level, measured 30 minutes before the start of magnetic resonance imaging, was used as a measure of recent ambient blood glucose levels in the present study. Unless experimentally controlled as in clamping technique studies, a wide range of glycemic variabilities in patients with clinically controlled T1DM due to differences in patients' fasting state, schedule for insulin treatment, a time lag between blood sampling and imaging, and duration of imaging decrease the reliability of current blood glucose levels as a measure of ambient blood glucose levels.
In our analysis with a subsample of 45 patients with T1DM, there was no significant relationship (unadjusted r = 0.109, P = .49; adjusted r = 0.141, P = .39) between current blood glucose levels and cerebral glucose levels, in contrast to reports of positive correlations in previous clamping studies of controlled blood glucose settings.
12 Furthermore, mean prefrontal glucose levels were significantly higher in 27 patients with T1DM (peripheral glucose levels 70-180 mg/dL; to convert to millimoles per liter, multiply by 0.0555) than in healthy control subjects, controlling for age, sex, and GM proportion (F 1,54 =13.82, PϽ .001). Mean prefrontal glucose levels of 18 patients (peripheral glucose levels Ͻ70 mg/dL or Ͼ180 mg/dL) were also higher than those of control subjects (F 1,47 =28.85, P Ͻ.001). There were no differences in prefrontal glucose levels between 2 subgroups (27 subjects with peripheral glucose levels 70-180 mg/dL vs 18 subjects with peripheral glucose levels Ͻ70 mg/dL or Ͼ180 mg/dL) (F 1,38 = 0.18, P = .67).
Consequently, as an exploratory analysis, the relationship between recent peripheral glycemic levels (current HbA 1c levels) and cerebral glucose levels was tested by means of the partial correlation analysis.
RESULTS
There was no significant correlation between current HbA 1c levels and cerebral glucose levels in healthy control subjects (unadjusted r = 0.199, P = .26; adjusted r=0.173, P =.34). When tested in patients with T1DM, correlations between current HbA 1c levels and cerebral glucose levels were significant (unadjusted r = 0.342, P Ͻ .001; adjusted r=0.357, PϽ .001).
As an exploratory analysis, correlations between current HbA 1c levels and cerebral glucose levels in each glycemic control T1DM subgroup were also assessed. Although there was no such correlation in the T1DM subgroup with good lifetime glycemic control (unadjusted r=0.052, P=.83; adjusted r=0.001, P=.99) , as there was in healthy control subjects, there were significant correlations between current HbA 1c level and cerebral glucose level in the T1DM subgroup with poor glycemic control (unadjusted r = 0.350, P = .001; adjusted r = 0.366, PϽ .001).
COMMENT
When the relationship between recent blood glycemic levels and cerebral glucose levels was separately evaluated in each of the 3 subgroups (normal, good, and poor glycemic control subgroups), a positive correlation between recent blood glycemic levels and cerebral glucose levels was observed only in the patients with T1DM who had poor glycemic control but not in those with good glycemic control or the healthy control subjects.
Although cerebral glucose levels were higher in patients with T1DM than in healthy control subjects, the pattern of associations in the subgroups indirectly suggests that diabetic subjects in the good glycemic control T1DM subgroup (HbA 1c Ͻ7%) can consistently maintain stable cerebral glucose levels despite variations in (REPRINTED) ARCH GEN PSYCHIATRY/ VOL 66 (NO. 8), AUG 2009 WWW.ARCHGENPSYCHIATRY.COM E1 recent blood glucose levels, as in healthy control subjects. In the poor glycemic control T1DM subgroup (HbA 1c Ն7%), however, cerebral glucose levels are more reflective of recent blood glycemic levels.
The current finding suggests that the capability of diabetic patients to maintain steady cerebral glucose levels is relatively well preserved in those with HbA 1c levels less than 7% but that decompensation starts in those with HbA 1c levels of 7% or greater.
eSUPPLEMENT 2
Spectral quality was determined quantitatively by the line width (full width at half maximum and the signal to noise ratio. The mean (SD) full width half maximum from the VOI was 0.053 (0.010) and 0.049 (0.007) ppm for both the T1DM and healthy control groups (range, 0.038-0.086). The mean (SD) values of the signal to noise ratio for T1DM and healthy control groups were 16.0 (2.4) and 16.4 (2.6), respectively, which were adequate for reliable metabolite peak fitting.
Reliability of fit for all metabolites was judged by the mean Cramer-Rao lower bound values (relative estimates of the uncertainty in the peak area determination). Spectral quantification of glucose and glutamate-glutamine-␣-aminobutyric acid (Glx) resonances was conducted cautiously because of the relatively low magnetic field strength. Fitting for glucose could not be conducted for 10 patients with T1DM and 4 control subjects because of poor reliability of determination. Estimates of Glx resonance in 4 patients with T1DM and 1 control subject were also excluded for the same reason. Abbreviations: Cr, creatine-phosphocreatine; CRLB, Cramer-Rao lower bound; Glx, glutamate-glutamine-␥-aminobutyric acid; NAA, N-acetyl aspartate-N-acetyl aspartyl glutamate.
a The mode, median, and mean CRLB values for prefrontal Glx levels of participants were all within the 20% range, which are generally considered to be well determined.
b The mode, median, and mean CRLB values for prefrontal glucose levels of patients with type 1 diabetes mellitus were 15%, 24%, and 31% in the present study. Higher mean CRLB values than mode and median values suggest that mean CRLB values were inflated by outliers of high cerebral glucose levels in the present study. Given that metabolites of which standard deviations are within the 20% range are generally considered to be well determined, confidence in quantifying cerebral glucose levels in this study appears to be limited. Sample spectra from patients with type 1 diabetes, however, exhibit relatively clear peaks of prefrontal glucose resonances (Figure 2 Abbreviations: Cr, creatine-phosphocreatine; Glx, glutamate-glutamine-␥-aminobutyric acid; NAA, N-acetyl aspartate-N-acetyl aspartyl glutamate. a A phantom with known physiologic concentrations of NAA, Cr, choline, myo-inositol, and Glx was repeatedly imaged weekly (on 134 separate occasions) during a study period of 2 1 ⁄2 years. On the basis of these data, coefficients of variation for each metabolite were calculated.
b Standard deviation divided by mean of measurement on 134 occasions ϫ100. a Data are age-, sex composition-, and educational level-adjusted z score (SD) values using group mean scores and standard deviations of healthy control subjects. A negative group mean z score indicates the number of standard deviation units lower than expected scores of healthy control subjects.
b Group differences were tested by independent t tests. c Patients with good glycemic control were defined as those with a lifetime average glycated hemoglobin level less than 7% (to convert to a proportion of total hemoglobin, multiply by 0.01). Patients with poor glycemic control were defined as those with a lifetime average glycated hemoglobin level of 7% or greater.
d Mean composite score was constructed by averaging z scores of neuropsychological tests of each cognitive domain. e Composite score for the global cognitive function was constructed by averaging mean z scores of all neuropsychological domains. A positive value indicates a good performance.
f Scores are presented in scale scores, not z scores.
